The effects for the 23-item Kansas City Cardiomyopathy Questionnaire (KCCQ) (A) and for the 12-item KCCQ (B) are described. To more simply understand how to interpret these figures, one can consider the physical limitation scale of the KCCQ-23.

The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item self-administered questionnaire developed to independently measure the patient’s perception of their health...

Apr 9, 2020 · This qualification statement supports the KCCQ-23 Total Symptom Score, Physical Limitations Score and Clinical Summary Score as measures of their respective concepts in drug development.

The Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life.

Aug 25, 2015 · In heart failure, the 23-item, disease-specific Kansas City Cardiomyopathy Questionnaire (KCCQ) has been shown to be valid, reliable, sensitive to clinical change, and prognostic of both clinical events and costs.

The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life.

Sep 1, 2021 · The KCCQ is a 23-item self-administered tool to measure patient-reported health status in patients with HF. 7 It assesses 7 domains, Physical Limitations (PL; 6 items), Symptom Stability (1 item), Symptom Frequency (SF; 4 items), Symptom Burden (SB; 3 items), Self-Efficacy (2 items), Quality of Life (QoL; 3 items), and Social Limitations (SL; 4 ...

The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire developed to provide a better description of HRQoL in patients with CHF. It quantifies, in a disease-specific fashion, physical limitation, symptoms (frequency, severity and recent change over time), QoL, social interference and self-efficacy.

Nov 1, 2020 · In heart failure, the Kansas City Cardiomyopathy Questionnaire (KCCQ) has been qualified by the U.S. Food and Drug Administration as a Clinical Outcome Assessment and recommended as a...

The KCCQ is a 23-item (15 question) self-administered questionnaire designed to quantify physical limitations, symptoms (frequency, severity and recent change over time), social limitations, self-efficacy, and quality of life. 10 All items are measured on a Likert scale with 5–7 response options. There are five individual subscales, and all ...